WNT10A and diffuse large B-cell lymphoma: Consistent with data in the database, immunohistochemical staining also revealed WNT10A overexpression in DLBCL patients, and higher WNT10A expression was associated with advanced clinical stages and poor overall survival (Figures 4G, –I).